Summary
Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biopharmaceutical company that offers discovery and development of new therapeutics that enable the body’s immune system . The company advances technologies which can control the immune activity and improve their ability to attack cancers, infections and autoimmune diseases. Its research programs comprise Major Histocompatibility Complex I, that restores the immune system’s ability to recognize and destroy cancer cells. Pascal Biosciences offers research on calcium channel blockers that modulates voltage-gated calcium channels for the signalling of immune system response and prevents transplant rejection. The company also provides CD74, a chaperone protein that aids the immune system to combat infections and cancers. Pascal Biosciences is headquartered in Vancouver, British Columbia, Canada.
Pascal Biosciences Inc (PAS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pascal Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Biommune Enters into Agreement with University of British Columbia 10
Equity Offering 10
BioMmune Technologies Raises USD0.4 Million in Private Placement of Units 10
BioMmune Raise USD0.8 Million in Private Placement of Units 11
Acquisition 12
MC Partners Acquires bioMmune Advanced Technologies in Reverse Takeover Transaction 12
Pascal Biosciences Inc - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Strategy And Business Planning 17
May 09, 2017: Pascal Biosciences Creates Development Science Lab in Seattle WA 17
Corporate Communications 18
Sep 20, 2016: BioMmune Appoints Thomas Gadek, PhD, to Board of Directors 18
Apr 22, 2016: BioMmune Appoints Dr. Patrick Gray as New Chief Executive Officer and President 19
Other Significant Developments 20
Mar 30, 2017: bioMmune Announces Name Change to Pascal Biosciences 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21List of Tables
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pascal Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pascal Biosciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Biommune Enters into Agreement with University of British Columbia 10
BioMmune Technologies Raises USD0.4 Million in Private Placement of Units 10
BioMmune Raise USD0.8 Million in Private Placement of Units 11
MC Partners Acquires bioMmune Advanced Technologies in Reverse Takeover Transaction 12
Pascal Biosciences Inc, Key Competitors 14
Pascal Biosciences Inc, Key Employees 15List of Figures
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
